An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting
| Autor: | Mustafa Ozguroglu, Hassan Errihani, B. Larbaoui, B.A. Slim, A. Mezlini, Irfan Cicin, M. Oukkal, K. Alsalef, Ruchan Uslu, Burce Goktas, R. Belbaraka, H. Mahfouf |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment Neo adjuvant 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Trastuzumab 030220 oncology & carcinogenesis Internal medicine medicine In patient Open label business Adjuvant medicine.drug Early breast cancer |
| Zdroj: | European Journal of Cancer. 92:S102-S103 |
| ISSN: | 0959-8049 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect